Cargando…

ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma

BACKGROUND: Therapeutic intervention in metastatic medulloblastoma is dependent on elucidating the underlying metastatic mechanism. We investigated whether an epithelial–mesenchymal transition (EMT)-like pathway could drive medulloblastoma metastasis. METHODS: A 3D Basement Membrane Extract (3D-BME)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasir, Aishah, Cardall, Alice, Othman, Ramadhan T, Nicolaou, Niovi, Lourdusamy, Anbarasu, Linke, Franziska, Onion, David, Ryzhova, Marina, Cameron, Hanna, Valente, Cara, Ritchie, Alison, Korshunov, Andrey, Pfister, Stefan M, Grabowska, Anna M, Kerr, Ian D, Coyle, Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080134/ https://www.ncbi.nlm.nih.gov/pubmed/33948561 http://dx.doi.org/10.1093/noajnl/vdab030

Ejemplares similares

Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma
por: Nasir, Aishah, et al.
Publicado: (2021)

MBRS-45. TWIST1 AND ABCB1 ARE FUNCTIONAL DETERMINANTS OF METASTASIS IN MEDULLOBLASTOMA
por: Cardall, Alice, et al.
Publicado: (2020)

3D hydrogels reveal medulloblastoma subgroup differences and identify extracellular matrix subtypes that predict patient outcome
por: Linke, Franziska, et al.
Publicado: (2020)

Overcoming multiple drug resistance mechanisms in medulloblastoma
por: Othman, Ramadhan T, et al.
Publicado: (2014)

The Molecular Landscape of Medulloblastoma in Teenagers and Young Adults
por: Mohammed, Omar J., et al.
Publicado: (2022)

Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature
por: Taylor, Louisa, et al.
Publicado: (2023)

Update on molecular and genetic alterations in adult medulloblastoma
por: Kool, Marcel, et al.
Publicado: (2012)

Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging
por: Linke, Franziska, et al.
Publicado: (2023)

MBRS-27. EXOSOMES CARRY DISTINCT miRNAs THAT DRIVE MEDULLOBLASTOMA PROGRESSION
por: Jackson, Hannah K, et al.
Publicado: (2020)

MBRS-28. EXOSOMES DRIVE MEDULLOBLASTOMA METASTASIS IN A MMP2 AND EMMPRIN DEPENDENT MANNER
por: Jackson, Hannah K, et al.
Publicado: (2020)

Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner
por: Jackson, Hannah K., et al.
Publicado: (2023)

Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potential
por: Smith, Stuart James, et al.
Publicado: (2020)

MBRS-43. ELUCIDATING HOW NOVEL EXTRACELLULAR MATRIX SUBTYPES DIFFERENTIALLY IMPACT THE SURVIVAL OF MEDULLOBLASTOMA SUBGROUPS
por: Johnson, James, et al.
Publicado: (2020)

MBRS-42. YB-1 - A NOVEL THERAPEUTIC TARGET IN HIGH-RISK MEDULLOBLASTOMA?
por: Taylor, Louisa, et al.
Publicado: (2020)

EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
por: Delaidelli, Alberto, et al.
Publicado: (2021)

Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching
por: Austin, Matt, et al.
Publicado: (2017)

PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study
por: Delaidelli, Alberto, et al.
Publicado: (2022)

MEDB-64. Are Rab GTPases metastatic drivers in metastatic medulloblastoma?
por: Entwistle, Susannah, et al.
Publicado: (2022)

3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination
por: Roper, Sophie J., et al.
Publicado: (2021)

MEDB-24. Tumour secreted extracellular matrix predicts survival and influences migration and cell death in SHH medulloblastoma 3D models
por: Johnson, James, et al.
Publicado: (2022)

Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines
por: Ivanov, D.P., et al.
Publicado: (2016)

Molecular subgroups of medulloblastoma: the current consensus
por: Taylor, Michael D., et al.
Publicado: (2011)

Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma
por: Chan, Tiffany S Y, et al.
Publicado: (2021)

Expression alterations define unique molecular characteristics of spinal ependymomas
por: Lourdusamy, Anbarasu, et al.
Publicado: (2015)

Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma
por: Bhatia, Bobby, et al.
Publicado: (2012)

Loss of Multiple ABCB Auxin Transporters Recapitulates the Major twisted dwarf 1 Phenotypes in Arabidopsis thaliana
por: Jenness, Mark K., et al.
Publicado: (2022)

MDB-34. “INDUCING IRON IMBALANCE BY TARGETING THE ABCB7/GPX4 AXIS ACCELERATES FERROPTOSIS IN MEDULLOBLASTOMA”
por: Kanchan, Ranjana, et al.
Publicado: (2023)

A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
por: Sabnis, Durgagauri H., et al.
Publicado: (2019)

microRNA network analysis identifies miR-29 cluster as key regulator of LAMA2 in ependymoma
por: Lourdusamy, Anbarasu, et al.
Publicado: (2015)

MEDB-60. Medulloblastoma with extensive nodularity mimics cerebellar development and differentiates along the granular precursor lineage
por: Ghasemi, David R, et al.
Publicado: (2022)

Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells
por: Robson, Jonathan P., et al.
Publicado: (2019)

Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses
por: Okonechnikov, Konstantin, et al.
Publicado: (2023)

MBRS-69. METABOLITE PROFILING OF SHH MEDULLOBLASTOMA IDENTIFIES A SUBSET OF CHILDHOOD TUMOURS ENRICHED FOR HIGH-RISK MOLECULAR BIOMARKERS AND CLINICAL FEATURES
por: Bennett, Christopher, et al.
Publicado: (2020)

MEDB-25. Do extracellular vesicles transfer a multidrug resistant phenotype via ABC transporters in medulloblastoma?
por: Wade, Philippa, et al.
Publicado: (2022)

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
por: Northcott, Paul A., et al.
Publicado: (2011)

MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS
por: Kumar, Rahul, et al.
Publicado: (2020)

Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
por: Ecker, Jonas, et al.
Publicado: (2015)

MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
por: Robinson, Giles W, et al.
Publicado: (2020)

Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression
por: Korshunov, Andrey, et al.
Publicado: (2022)

Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
por: Krausert, Sonja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_th1smvub641d0b9meb542rnhvn